300896.SZ Stock Analysis
30
Uncovered
Imeik Technology Development Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
High score
Imeik Technology Development Co., Ltd. engages in the research, development, and transformation of biomedical materials, with a focus on recombinant proteins and peptides. The company is headquartered in Beijing, Beijing and currently employs 507 full-time employees. The company went IPO on 2020-09-28. The firm focuses on the development and transformation of biomedical materials, and is committed to the development of biomedicine such as recombinant proteins and peptides. The firm has realized the industrialization of injection-type sodium hyaluronate series products and polydioxanone facial implants, and has established a product technology transformation platform for biomedical materials such as medical chitosan and polylactic acid. The firm's self-developed products are mainly aimed at the repair of fold skin on the face and neck. The clinical applications of its products cover medical cosmetology, surgical repair, and treatment of metabolic diseases. The firm mainly conducts its businesses in the China market.